Arrhythmias & electrophysiologyTrial design
The HONEST Cohort Study
- French nationwide, single-arm, observational ongoing study
- Clinical endpoints are centrally adjudicated
Study context
- Population
- All patients who underwent implantation of an subcutaneous implantable cardioverter-defibrillator (S-ICD) (EMBLEM, Boston Scientific) in France between October 2012 and December 201977% males, 49.9 years, 98.2% of all S-ICD implantations during the study period in France
- Participants
- 4,924 patients
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
The HONEST Cohort Study. JACC Adv. doi:10.1016/j.jacadv.2026.102604
Summarised from the published abstract; every number is checked against it